Legend Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-287
Closed -$80K 41
2025
Q2
$80K Buy
+287
New +$81.3K 0.05% 46
2025
Q1
Sell
-381
Closed -$99.3K 43
2024
Q4
$99.3K Hold
381
0.07% 41
2024
Q3
$123K Sell
381
-94
-20% -$30.7K 0.08% 40
2024
Q2
$148K Sell
475
-9
-2% -$2.64K 0.11% 45
2024
Q1
$138K Buy
484
+33
+7% +$9.66K 0.1% 42
2023
Q4
$130K Buy
451
+18
+4% +$4.9K 0.1% 41
2023
Q3
$116K Sell
433
-72
-14% -$18K 0.1% 49
2023
Q2
$112K Buy
505
+24
+5% +$5.57K 0.09% 49
2023
Q1
$116K Sell
481
-25
-5% -$6.14K 0.1% 45
2022
Q4
$133K Buy
506
+72
+17% +$19.3K 0.12% 47
2022
Q3
$97.6K Buy
+434
New +$105K 0.09% 46

Other funds holding AMGN

Legend Financial Advisors's AMGN Position: Q3 2025 in Review

Legend Financial Advisors sold out of Amgen (AMGN) in Q3 2025, closing a stake of 287 shares — an estimated $80K sold.

Legend Financial Advisors first reported a position in AMGN in Q3 2022 and held it in 11 quarters. The position peaked at $148K in Q2 2024. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Legend Financial Advisors reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Legend Financial Advisors sold 287 Amgen shares in Q3 2025, an estimated $80K.
  • Legend Financial Advisors first reported a position in Amgen in Q3 2022 and held it in 11 quarters.
  • Legend Financial Advisors's Amgen position peaked at $148K in Q2 2024.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Legend Financial Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.